Knowledge Center
Poster / Nov 12, 2017
Optimizing Disintegration in Tablets of Amorphous Solid Dispersions
Source:
AAPS 2017
Good bioavailability of amorphous solid dispersions (ASDs) not only depends on dissolution rate/extent but also on the capability to inhibit/avoid crystallization, ensuring that supersaturated state is retained to promote absorption. Here, the type and amount of carrier polymer used in ADSs preparation have a strong impact on the rate and extent of precipitation.
Related links
Also in the Knowledge Center
/ Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Read more
Scientific Article
/ Nov 12, 2024
Webinar - Solving the Insoluble: Webinar on the Science and Application of the Dispersome® Technology
Read more
Scientific Article
/ Oct 29, 2024
Comparison of Traditional and Mechanochemical Production Processes for Nine Active Pharmaceutical Ingredients (APIs)
Read more
Scientific Article